Research announcement · Cambridge University Hospitals · 2026-10-23

A Cambridge-led team presented results from 3,866 people who received their usual dialysis care with or without additional vitamin D3.

The SIMPLIFIED trial asked whether adding high-dose vitamin D3 to usual care helped people on dialysis live longer. Fifty-five UK renal units took part. The investigators used routine health records to follow participants over several years.

At an American Society of Nephrology meeting, the researchers reported 881 deaths among 1,940 participants assigned extra vitamin D3 and 936 among 1,926 assigned usual care. The overall survival comparison did not reach statistical significance.

The protocol used an open-label design, so the participants and their care teams knew which group they were in. Both groups could continue to receive the treatments ordinarily available to people on dialysis.